Linda Malek
Overview
Linda Malek is a partner in Crowell’s Health Care and Privacy & Cybersecurity Groups, where she advises a broad array of health care and life sciences clients on compliance with federal, state, and international law governing clinical research, data privacy, cybersecurity, and fraud and abuse. Her clients include national hospitals systems and academic medical centers, genetic and biotechnology companies, pharmaceutical companies, medical device companies, financial institutions involved in healthcare services, research foundations and international scientific organizations.
Career & Education
- New York
Office of the Corporation Counsel, Division of Legal Counsel, 1993–1999
- New York
- Walla Walla University, B.A., cum laude
- University of Virginia School of Law, J.D.,
Editorial Board Member, Journal of Law and Politics
Recipient, Mary Claiborne and Roy H. Ritter Award, The University of Virginia School of Law
- New York
- Board Member, NYBIO
- Trustee, Lucy B. Moses Foundation
- Former member of Educational Advisory Board, International Association of Privacy Professionals
- Founding Board, National Board of Health Lawyers, a division of NBTA (National Board of Trial Advocacy)
- American Bar Association, Health Reform Task Force
- American Health Lawyers Association
- French
Linda's Insights
Client Alert | 9 min read | 11.06.24
Proposed Rule on Protecting Bulk Sensitive Data and Its Impact on Health Care
On October 29, 2024, the Department of Justice (DOJ) published a Notice of Proposed Rulemaking (NPRM) to implement Executive Order 14117 “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern” (the E.O.). The E.O. addresses the national security threat posed by the continued effort of certain countries of concern to access and exploit certain kinds of Americans’ sensitive personal data, which includes health data and genetic data. This builds on DOJ’s Advance Notice of Proposed Rulemaking (ANPRM) published on March 5. Comments are due on November 29, 2024.
Client Alert | 4 min read | 10.29.24
Recognition
- Chambers USA: Up and Coming: Heatlhcare, 2024
- Best Lawyers in America: 2022–2024
- Super Lawyers: 2013–2024
Linda's Insights
Client Alert | 9 min read | 11.06.24
Proposed Rule on Protecting Bulk Sensitive Data and Its Impact on Health Care
On October 29, 2024, the Department of Justice (DOJ) published a Notice of Proposed Rulemaking (NPRM) to implement Executive Order 14117 “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern” (the E.O.). The E.O. addresses the national security threat posed by the continued effort of certain countries of concern to access and exploit certain kinds of Americans’ sensitive personal data, which includes health data and genetic data. This builds on DOJ’s Advance Notice of Proposed Rulemaking (ANPRM) published on March 5. Comments are due on November 29, 2024.
Client Alert | 4 min read | 10.29.24
Insights
How Health Cos. Can Brace For Tracking Tech Scrutiny
|08.24.23
Law360
Theories of AI Liability: It’s Still About the Human Element
|09.20.22
Reuters
Data Privacy and Artificial Intelligence in Health Care
|03.17.22
Reuters
Government Oversight in Managing Risks of AI in Health Care
|01.12.22
Reuters
Significance of FTC Guidance on Artificial Intelligence in Health Care
|11.24.21
Reuters Legal
INSIGHT: Advice for Digital Health Developers During Covid-19
|05.05.20
Bloomberg Law
Proposed Privacy Laws Put Genetic Testing Cos. In Hot Seat
|02.24.20
Law360
INSIGHT: Modernizing the Approach to Regulating Software as a Medical Device
|06.10.19
Bloomberg Law
Genetic Testing Is On FTC's Radar
|04.18.19
Law360
Higher Education & Healthcare Research Compliance Conference
|06.12.24
"Spotlight on Health Equity in Clinical Trials," 2nd Annual Westchester Life Sciences Showcase, New York
|05.01.24
"Best Practices in Recruiting for Health Equity: Designing a Successful Protocol for Recruitment," Clinical Trials Masterclass, New York, NY
|03.13.24
"Future of Clinical Trials," Clinical Trials Masterclass, New York, NY
|03.13.24
"Presentation of Attendee Clinical Trial Site Checklist: Feedback from Professionals," Clinical Trials Masterclass, New York, NY
|03.13.24
DOJ Official Calls Uber Security Chief Conviction An 'Outlier'
|12.09.22
Law360
Why FDA's Medical Device Cyber Recommendations 'Have Teeth'
|05.27.22
Healthcare Info Security
3 Key Details To Watch As Congress Mulls Breach Report Law
|12.24.21
Law360
Top Healthcare Cybersecurity Predictions For Next Year
|12.16.21
Healthcare Info Security
Feds Will Weigh Whether Cyber Best Practices Were Followed When Assessing HIPAA Fines
|01.11.21
SC Magazine
The Virus Shot Goes in Your Arm, but Where Does Your Data Go?
|09.23.20
Bloomberg Law
Protecting AI in Healthcare: Addressing Algorithmic Bias, Data Privacy, Security
|07.18.22
Healthcare Strategies
2022 Expert Predictions Part Two: Digital Health Solutions, Security Trends
|01.10.22
Healthcare Strategies
FDA Calls Out a Migraine TV Ad for Misleading Viewers
|10.17.24
Crowell Health Solution’s Trends in Transformation
FDA Publishes FAQs Around Its Recent Laboratory Developed Tests Final Rule
|08.12.24
Crowell Health Solution’s Trends in Transformation
FDA Issues Guidance on Using Electronic Health Records and Medical Claims Data in Clinical Studies
|08.01.24
Crowell Health Solution’s Trends in Transformation
New Federal Guidelines for Research Security Programs at Covered Institutions
|07.22.24
Crowell Health Solution’s Trends in Transformation
- |
07.16.24
Crowell Health Solution’s Trends in Transformation
Linda's Insights
Client Alert | 9 min read | 11.06.24
Proposed Rule on Protecting Bulk Sensitive Data and Its Impact on Health Care
On October 29, 2024, the Department of Justice (DOJ) published a Notice of Proposed Rulemaking (NPRM) to implement Executive Order 14117 “Preventing Access to Americans’ Bulk Sensitive Personal Data and United States Government-Related Data by Countries of Concern” (the E.O.). The E.O. addresses the national security threat posed by the continued effort of certain countries of concern to access and exploit certain kinds of Americans’ sensitive personal data, which includes health data and genetic data. This builds on DOJ’s Advance Notice of Proposed Rulemaking (ANPRM) published on March 5. Comments are due on November 29, 2024.
Client Alert | 4 min read | 10.29.24